Alkermes (ALKS) Cost of Revenue (2010 - 2026)

Alkermes (ALKS) has 17 years of Cost of Revenue data on file, last reported at $155.6 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $155.6 million, up 26.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $440.9 million (up 26.5% YoY), and the FY2025 annual result was $480.0 million, up 95.66% from the prior year.
• Cost of Revenue rose to $155.6 million in Q1 2026 per ALKS's latest filing, from $120.3 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $155.6 million in Q1 2026 and troughed at $49.5 million in Q2 2025.
• A 5-year average of $81.5 million and a median of $62.1 million in 2024 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2024 and 2025: Cost of Revenue soared 115.97% in 2024, then declined 19.54% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $53.9 million in 2022, then jumped by 30.05% to $70.1 million in 2023, then decreased by 11.42% to $62.1 million in 2024, then soared by 93.62% to $120.3 million in 2025, then grew by 29.34% to $155.6 million in 2026.
• Business Quant data shows ALKS's Cost of Revenue at $155.6 million in Q1 2026, $120.3 million in Q4 2025, and $115.6 million in Q3 2025.